Mouse KLF11 regulates hepatic lipid metabolism

Area of Science:

• Molecular biology
• Metabolic research
• Genetics

Background:

• Missense mutations in Krüppel-like factor 11 (KLF11) are linked to diabetes due to impaired insulin synthesis.
• The role of KLF11 in peripheral tissues, particularly in lipid metabolism, remains largely unexplored.

Purpose of the Study:

• To investigate the function of KLF11 in regulating hepatic lipid homeostasis.
• To elucidate the molecular mechanisms underlying KLF11's role in liver fat metabolism using mouse models.

Main Methods:

• Adenovirus-mediated delivery of KLF11 or KLF11-specific shRNA in db/db diabetic, high-fat diet-induced obese (DIO), and C57BL/6J mice.
• Histological and biochemical analyses of liver phenotype and triglyceride levels.
• Exploration of the molecular pathways, including PPARα signaling, involved in KLF11-mediated lipid regulation.

Main Results:

• KLF11 expression is dysregulated in the livers of db/db and DIO mice.
• KLF11 overexpression in db/db and DIO mice activates PPARα signaling, improving fatty liver.
• KLF11 knockdown increases hepatic triglyceride levels by decreasing fatty acid oxidation, a process dependent on PPARα activity.

Conclusions:

• KLF11 plays a critical role in regulating hepatic lipid metabolism.
• KLF11 influences liver fat accumulation through the PPARα signaling pathway.
• KLF11 represents a potential therapeutic target for managing hepatic steatosis and related metabolic disorders.